2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.

$258.9M

Market Cap • 3/13/2025

2021

(4 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Cambridge

Headquarters • Massachusetts